Copyright 2004 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.2004
Since its first description more than a century ago, there has been much debate about the diagnostic entity polymyositis. Because initial observations were of individuals with dermatomyositis, it appeared that polymyositis was not possible without skin lesions. Distinctive clinical and histologic features of polymyositis were not established until the late 20th century. The identification of inclusion body myositis as a distinct entity has further refined nosographic classification.
Bronner IM, Linssen WHJP, van der Meulen MFG, Hoogendijk JE, de Visser M. Polymyositis: An Ongoing Discussion About a Disease Entity. Arch Neurol. 2004;61(1):132–135. doi:10.1001/archneur.61.1.132
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: